Aprea Therapeutics, Inc. Business Finance Contracts & Agreements
15 Contracts & Agreements
- Purchase Agreements (1 contract)
- Registration Rights Agreements (3)
- Stock Agreements (6)
- Underwriting Agreements (2)
- Warrant Agreements (3)
- Aprea Therapeutics, Inc. Inducement Restricted Stock Unit Award Agreement, dated May 1, 2024, by and between Aprea Therapeutics, Inc. and Nadeem Q. Mirza, M.D., M.P.H (Filed With SEC on May 14, 2024)
- Aprea Therapeutics, Inc. Inducement Stock Option Agreement, dated May 1, 2024, by and between Aprea Therapeutics, Inc. and Nadeem Q. Mirza, M.D., M.P.H (Filed With SEC on May 14, 2024)
- Form of Registration Rights Agreement, dated as of March 11, 2024, by and between Aprea Therapeutics and the purchasers (Filed With SEC on March 12, 2024)
- Form of Securities Purchase Agreement, dated as of March 11, 2024, by and between Aprea Therapeutics, Inc. and the purchasers named therein (Filed With SEC on March 12, 2024)
- Form of Tranche B Warrant (Filed With SEC on March 12, 2024)
- Form of Tranche A Warrant (Filed With SEC on March 12, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 12, 2024)
- Underwriting Agreement, dated as of February 22, 2023, between Aprea Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on February 24, 2023)
- Form of Registration Rights Agreement, by and among Aprea and certain securityholders (Filed With SEC on May 17, 2022)
- Description of the Companys Common Stock, $0.001 par value (Filed With SEC on March 16, 2021)
- Description of the Companys Common Stock, $0.001 par value (Filed With SEC on March 27, 2020)
- Specimen common stock certificate of the Registrant (Filed With SEC on September 27, 2019)
- Form of Amended and Restated Registration Rights Agreement, by and among the Registrant and the shareholders party thereto (Filed With SEC on September 25, 2019)
- Form of 2019 Employee Stock Purchase Plan and form of agreements thereunder (Filed With SEC on September 25, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 23, 2019)
